Isomorphic Labs is racing to become the world's first AI drug company worth over $50 billion. Founded by Demis Hassabis, the firm aims to commercialize AlphaFold's Nobel Prize-winning protein-folding breakthrough into real medicines, partnering with Eli Lilly and Novartis. Critics warn of a massive gap between predicting protein structures and producing FDA-approved drugs — decades and billions spent on failed trials remain essential. Isomorphic claims $5 billion will fund robotic labs and massive compute to accelerate discovery, but without human trial data, the entire enterprise hinges on whether AI can truly substitute for years of clinical work. The real debate Can AI end up as humanity's doctor, or is this a costly experiment? Tools used for generation Text Gemini Narator Azure TTS Clips Pexel Rendering Remotion

New tool gives users creative control over AI art generators, moving beyond simple text prompts for better results.

A description of the event. Tools used for generation Text Gemini Narator Azure TTS Clips Pexel Rendering Remotion